What is Antares Therapeutics worth?
$299.0Mlast known valuation
Antares Therapeutics last raised $30.0M in its Early Stage VC (May 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Antares Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2025 | Early Stage VC | $30.0M | ▮ | ▮ |
| Mar 2025 | Early Stage VC | $40.0M | ▮ | ▮ |
How Antares Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Antares Therapeutics, we compose those signals into the PA Mark — a weighted composite of 1 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Antares Therapeutics worth?
- Antares Therapeutics's implied valuation is $299.0M, based on the PA Mark composite price of about $1 per share as of Sep 2026.
- How much has Antares Therapeutics raised?
- Antares Therapeutics has raised $177.0M in total funding across 2 recorded rounds.
- When did Antares Therapeutics last raise?
- Antares Therapeutics last raised in May 2025 (Early Stage VC), raising $30.0M.